Evidence map›Paper›PMID 18555851›Full record

ReviewMetabolism: clinical and experimental2008

A natural history of botanical therapeutics.

Barbara Schmidt, David M Ribnicky, Alexander Poulev, Sithes Logendra, William T Cefalu, Ilya Raskin

Registry-linked trialAbstract readHistorical ArticleReview
In one paragraph

Review in Metabolism: clinical and experimental, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01461798 (Assessment of the Efficacy of Plant Stanol Esters in Reducing Cholesterol, Medellin 2011), which is not on this map. Cited by 87 papers.

0numbers the graph read from it
0cells of the map it votes in
87citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01461798 naunknown statusnot on this mapstarted 2011, after this paper: background citation

Assessment of the Efficacy of Plant Stanol Esters in Reducing Cholesterol, Medellin 2011

TypeinterventionalSponsorJose María Maya MejíaRan2011 to 2012Enrolled40ConditionsRisk Reduction BehaviorArmsassessment of efficacy of Benecol yogurt, Placebo Yogurt, yogurt
3 · Its place in the literature

Who cites it

87 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Life (Basel, Switzerland) · 2026
    Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Food science & nutrition · 2025
    Article
  9. Article
  10. Article
  11. An Updated Comprehensive Review of Plants and Herbal Compounds with Antiasthmatic Effect.Evidence-based complementary and alternative medicine : eCAM · 2024
    Review
  12. Frontiers in clinical diabetes and healthcare · 2024
    Review
  13. Article
  14. Smart nanoparticles for cancer therapy.Signal transduction and targeted therapy · 2023
    Review
  15. Review
  16. Pharmaceutics · 2023
    Article
  17. Antioxidants (Basel, Switzerland) · 2023
    Review
  18. JAK/STAT signaling in diabetic kidney disease.Frontiers in cell and developmental biology · 2023
    Review
  19. Article
  20. The Effect ofInternational journal of molecular sciences · 2022
    Article

27 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Barbara SchmidtBiotechnology Center for Agriculture and the Environment, Cook College, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901-8520, USA.
David M Ribnicky
Alexander Poulev
Sithes Logendra
William T Cefalu
Ilya Raskin

Funding

Pregnane and Glycosides and Obesity/llya RaskinP50AT002776 · NCCIH · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI RIBNICKY, DAVID M · 2005 to 2019
$24.9M
Building New Pharmaceutical Capabilities in Central AsiaU01TW006674 · FIC · RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK · PI RASKIN, ILYA · 2003 to 2008
$4.1M
FIC NIH HHS U01 TW006674NCCIH NIH HHS P50 AT002776
6 · The paper itself

Abstract

Plants have been used as a source of medicine throughout history and continue to serve as the basis for many pharmaceuticals used today. Although the modern pharmaceutical industry was born from botanical medicine, synthetic approaches to drug discovery have become standard. However, this modern approach has led to a decline in new drug development in recent years and a growing market for botanical therapeutics that are currently available as dietary supplements, drugs, or botanical drugs. Most botanical therapeutics are derived from medicinal plants that have been cultivated for increased yields of bioactive components. The phytochemical composition of many plants has changed over time, with domestication of agricultural crops resulting in the enhanced content of some bioactive compounds and diminished content of others. Plants continue to serve as a valuable source of therapeutic compounds because of their vast biosynthetic capacity. A primary advantage of botanicals is their complex composition consisting of collections of related compounds having multiple activities that interact for a greater total activity.

Indexed as

Biological ProductsDietary SupplementsDrug DesignDrug SynergismHistory, 19th CenturyHistory, 20th CenturyHistory, 21st CenturyHumansPhytotherapyPlant ExtractsUnited StatesBiological ProductsPlant Extracts

Identifiers

PMID18555851
PMCPMC2981029

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.